2862 lines
44 KiB
HTML
2862 lines
44 KiB
HTML
<!doctype html public "-//W3C//DTD HTML 4.01 Transitional//EN">
|
|
<html lang="en">
|
|
|
|
<head>
|
|
|
|
<title>NLM Classification, 5th Edition Additions and Changes List 3. NLM Technical Bulletin. Nov-Dec 1998 </title>
|
|
<meta name="DC.Subject.IssueCover" content="/pubs/techbull/nd98/nd98_technote.html" />
|
|
|
|
<meta name="DC.Subject.IssueNum" content="305" />
|
|
<!--do not remove!! nlm survey script - contact wwwnlm@nlm.nih.gov with questions -->
|
|
<script src="/share/scripts/survey.js" type="text/javascript" language="javascript"></script>
|
|
<meta name="DC.Subject.Keyword" content="Abstract" />
|
|
<meta name="DC.Subject.Keyword" content="Animal" />
|
|
<meta name="DC.Subject.Keyword" content="Cataloging" />
|
|
<meta name="DC.Subject.Keyword" content="Chemistry" />
|
|
<meta name="DC.Subject.Keyword" content="Dietary Supplements" />
|
|
<meta name="DC.Subject.Keyword" content="Edition" />
|
|
<meta name="DC.Subject.Keyword" content="General Note" />
|
|
<meta name="DC.Subject.Keyword" content="Genetics" />
|
|
<meta name="DC.Subject.Keyword" content="MeSH Terms" />
|
|
<meta name="DC.Subject.Keyword" content="National Library of Medicine" />
|
|
<meta name="DC.Subject.Keyword" content="NLM Classification" />
|
|
<meta name="DC.Subject.Keyword" content="NLM Technical Bulletin" />
|
|
<meta name="DC.Subject.Keyword" content="Update" />
|
|
</head>
|
|
|
|
<body bgcolor="#f0f0f0" link="#083184" vlink="#960044"><noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-MT6MLL" height="0" width="0" style="display:none;visibility:hidden" title="googletagmanager"></iframe></noscript><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-MT6MLL');</script>
|
|
<style type="text/css">
|
|
#skip, .skip, .skipnavigation {
|
|
position:absolute;
|
|
left:0px;
|
|
top:-500px;
|
|
width:1px;
|
|
height:1px;
|
|
overflow:hidden;
|
|
}
|
|
</style>
|
|
<div class="skipnavigation"><a title="Skip the navigation on this page" href="#skipnav" class="skipnavigation">Skip Navigation Bar</a></div>
|
|
|
|
<a href="/nlmhome.html"><img src="/pubs/techbull/tb_graphics/tbhead4.gif" border=0 alt="NLM Technical Bulletin"/></a>
|
|
|
|
<h3><em>NLM Technical Bulletin.</em> 1998 November-December; 305</h3>
|
|
|
|
|
|
|
|
<hr />
|
|
|
|
<a id="skipnav" name="skipnav"></a>
|
|
<table border=0 cellspacing=0 cellpadding=10>
|
|
|
|
<tr>
|
|
|
|
<td valign=top bgcolor="#CB9966" width=140>
|
|
|
|
<hr />
|
|
|
|
<center><strong>In This Issue:</strong></center>
|
|
|
|
<hr />
|
|
|
|
<p>
|
|
|
|
<a href="/pubs/techbull/nd98/nd98_technote.html">Technical Notes</a> - e1
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
<a href="/pubs/techbull/nd98/nd98_gold.html">Gold Standard Search</a> - e2
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
<img src="/pubs/techbull/tb_graphics/blutri.gif" alt="dot" height=10 width=10/>NLM Classification, 5th Edition Additions and Changes List 3 - e3
|
|
|
|
</p>
|
|
|
|
<hr />
|
|
<center><strong><a href="/pubs/techbull/current_issue.html">Current Issue</a></strong></center>
|
|
|
|
<hr />
|
|
<center><strong><a href="/pubs/techbull/tb.html">Home</a></strong></center>
|
|
|
|
<hr />
|
|
<center><strong><a href="/pubs/techbull/back_issues.html">Back Issues</a></strong></center>
|
|
|
|
<hr />
|
|
<center><strong><a href="/pubs/techbull/new_index.html">Index</a></strong></center>
|
|
<hr />
|
|
</td>
|
|
|
|
|
|
|
|
<td valign=top width=440>
|
|
|
|
|
|
|
|
<center><h2>NLM Classification, 5th Edition</h2></center>
|
|
|
|
<center><h2>Additions and Changes List 3</h2></center>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
The following additions and changes to the fifth edition of the <em>NLM Classification</em> have been
|
|
|
|
made since the issuance of <a href="http://www.nlm.nih.gov/pubs/techbull/nd97/nd97_class.html">Additions and Changes, List 2</a>, announced in the November-December
|
|
|
|
1997 issue of the <em>NLM Technical Bulletin</em>. The Cataloging Section conducted a systematic
|
|
|
|
review of the new 1998 MeSH terms to determine the need for additions and changes to the
|
|
|
|
classification. The resulting additions and changes are presented in chart form in the following
|
|
|
|
categories: <a href="#tableg">Addition/Deletion in Table G</a>, <a href="#new">New Classification Numbers Added</a>, <a href="#addchange">Additions/Changes
|
|
|
|
in the Main Schedules</a>, <a href="#addindex">Additions in the Index</a>, and <a href="#index">Notable Changes in the Index</a>.
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<center><strong><a name="tableg" id="tableg">Addition/Deletion in Table G</a></strong></center>
|
|
|
|
|
|
|
|
<table width=440>
|
|
|
|
|
|
|
|
<tr valign=top><td width=100></td><td width=100></td><td width=240></td></tr>
|
|
|
|
|
|
|
|
<tr valign=top><td width=100>Addition:</td><td width=100>HC6</td><td width=240>Congo (Democratic Republic)</td></tr>
|
|
|
|
<tr valign=top><td width=100>Deletion:</td><td width=100>HZ15</td><td width=240>Zaire</td></tr>
|
|
|
|
</table>
|
|
|
|
|
|
|
|
<br />
|
|
|
|
<br />
|
|
|
|
|
|
|
|
<center><strong><a name="new" id="new">New Classification Numbers Added</a></strong></center>
|
|
|
|
|
|
|
|
<table width=440>
|
|
|
|
|
|
|
|
<tr valign=top><td width=100></td><td width=320></td></tr>
|
|
|
|
|
|
|
|
<tr valign=top><td width=100>WI 715</td><td width=320>Hepatitis (General or not elsewhere classified)</td></tr>
|
|
|
|
<tr valign=top><td width=100>WK 148</td><td width=320>Endocrine surgical procedures (General)</td></tr>
|
|
|
|
</table>
|
|
|
|
|
|
|
|
<br />
|
|
|
|
<br />
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<center><strong><a name="addchange" id="addchange">Additions/Changes in the Main Schedules</a></strong></center>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Note: In the chart below, new numbers and their associated headings are italicized.
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<table width=440>
|
|
|
|
|
|
|
|
<tr valign=top><td width=220></td><td width=220></td></tr>
|
|
|
|
|
|
|
|
<tr valign=top><td width=220><strong>Page Reference</strong></td><td width=220><strong>Change/Addition</strong></td></tr>
|
|
|
|
|
|
|
|
<tr valign=top><td width=220>p. 131</td><td width=220>add: <em>WI 715 Hepatitis (General or not elsewhere classified)</em></td></tr>
|
|
|
|
|
|
|
|
<tr valign=top><td width=220>p. 142</td><td width=220>add: <em>WK 148 Surgery (General)</em></td></tr>
|
|
|
|
|
|
|
|
<tr valign=top><td width=220>p. 172</td><td width=220>add * to WO 232.1</td></tr>
|
|
|
|
|
|
|
|
<tr valign=top><td width=220>p. 172</td><td width=220>add * to WO 233.1</td></tr>
|
|
|
|
|
|
|
|
<tr valign=top><td width=220>p. 188</td><td width=220>add * to WR 32.1</td></tr>
|
|
|
|
|
|
|
|
<tr valign=top><td width=220>p. 228</td><td width=220>add * to WY 31</td></tr>
|
|
|
|
|
|
|
|
</table>
|
|
|
|
|
|
|
|
<br /><br />
|
|
|
|
|
|
|
|
<center><strong><a name="addindex" id="addindex">Additions in the Index</a></strong></center>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Note: In the chart below, index entries for new numbers added are italicized.
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Acneiform Eruptions WR 430
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Aging, Premature</dt>
|
|
|
|
<dd>In infancy & childhood WS 104</dd>
|
|
|
|
<dd> See also Progeria WS 104</dd>
|
|
|
|
<dd> In adulthood (General, not associated with specific
|
|
|
|
disease,</dd>
|
|
|
|
<dd> life style, or pathological process) WT 104</dd>
|
|
|
|
<dd>In adulthood in association with general pathological</dd>
|
|
|
|
<dd> processes QZ 45
|
|
|
|
<dl>
|
|
|
|
<dd>In association with specific diseases or behaviors, with the</dd>
|
|
|
|
<dd> disease or behavior</dd>
|
|
|
|
<dd>Genetics QZ 45</dd>
|
|
|
|
<dd>See also Werner Syndrome QZ 45</dd>
|
|
|
|
</dl>
|
|
</dd>
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Alcohol-Related Disorders WM 274
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Animal Structures</dt>
|
|
|
|
<dd>Domestic animals SF 761-767</dd>
|
|
|
|
<dd>Wild animals QL 801-950.9</dd>
|
|
|
|
<dd>See also names of specific animals, groups of animals, or
|
|
|
|
specific</dd>
|
|
|
|
<dd> animal organ or structure</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Arrhythmogenic Right Ventricular Dysplasia WG 330
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Attention Deficit and Disruptive Behavior Disorders</dt>
|
|
|
|
<dd>General and in infancy & childhood WS 350.6</dd>
|
|
|
|
<dd>In adulthood WM 190</dd>
|
|
|
|
<dd>See also Conduct Disorder WS 350.6, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Back Injuries WE 720-755
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Bacterial Physiology QW 52
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Biological Phenomena</dt>
|
|
|
|
<dd>General QH 307-307.2</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Biological Therapy</dt>
|
|
|
|
<dd>General works WB 365</dd>
|
|
|
|
<dd>Of a particular disease, with the disease</dd>
|
|
|
|
<dd>See also names of specific therapies, e.g.,</dd>
|
|
|
|
<dd> Immunotherapy QW 940-949; Organotherapy WB 391</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Biomedical and Dental Materials</dt>
|
|
|
|
<dd>Biomedical and biocompatible materials QT 37</dd>
|
|
|
|
<dd>Dental materials WU 190</dd>
|
|
|
|
<dd>Used for special purposes, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Blepharoplasty WW 205
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Blood Coagulation Factor Inhibitors WH 310<dt>
|
|
|
|
<dd>Clinical examination QY 410</dd>
|
|
|
|
<dd>Pharmacology QV 193</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Blood Physiology WH 100
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Blood Vessel Prosthesis Implantation WG 170</dt>
|
|
|
|
<dd>Of a particular region or organ, with the region or organ</dd>
|
|
|
|
<dd>See also names of specific vessels, e.g.,</dd>
|
|
|
|
<dd> Coronary Vessels WG 300</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Body Temperature Changes</dt>
|
|
|
|
<dd>Physiology QT 165</dd>
|
|
|
|
<dd>In antibody formation QW 575</dd>
|
|
|
|
<dd>In infancy & childhood WS 141</dd>
|
|
|
|
<dd>In ovulation WP 540</dd>
|
|
|
|
<dd>In physical examination WB 270</dd>
|
|
|
|
<dd>See also Body Temperature WB 270, etc.; Body Temperature</dd>
|
|
|
|
<dd> Regulation QT 165, etc.; Fever WB 152, etc.;</dd>
|
|
|
|
<dd> Hypothermia WD 670, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Body Weight Changes</dt>
|
|
|
|
<dd>In infancy & childhood WS 103</dd>
|
|
|
|
<dd>Signs and symptoms WB 146</dd>
|
|
|
|
<dd>See also Body Weight GN 66, etc.; Obesity WD 210-212;</dd>
|
|
|
|
<dd> Thinness GN 66-67.5, etc.;</dd>
|
|
|
|
<dd> Weight Gain WS 103; Weight
|
|
|
|
Loss WS 103</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Body Weights and Measures</dt>
|
|
|
|
<dd>In adulthood GN 66</dd>
|
|
|
|
<dd>In infancy & childhood WS 103
|
|
|
|
<dl>
|
|
|
|
<dd>Tables WS 16</dd>
|
|
|
|
</dl>
|
|
</dd>
|
|
<dd>See also Anthropometry GN 51-59; Body Height GN 66,</dd>
|
|
|
|
<dd> etc.; Body Weight GN 66, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Bone Diseases, Endocrine WE 250
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Bone Marrow Cells WH 380
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Bones of Upper Extremity WE 805</dt>
|
|
|
|
<dd>See also names of specific parts of arm, e.g., Shoulder WE 810</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Breast Implantation WP 910
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Carbon Compounds, Inorganic QD 181.C1</dt>
|
|
|
|
<dd>Pharmacology QV 138.C1</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Cardiomyoplasty WG 169
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Cardiovascular Abnormalities WG 220
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Cardiovascular Physiology WG 102
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Cardiovascular Surgical Procedures WG 168-169.5
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Cell Aging</dt>
|
|
|
|
<dd>General QH 608
|
|
|
|
<dl>
|
|
|
|
<dd>Human WT 104</dd>
|
|
|
|
<dd>Plants QK 725</dd>
|
|
|
|
</dl>
|
|
</dd>
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Cell Physiology QH 631
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Central Nervous System Infections</dt>
|
|
|
|
<dd>Diagnosis WL 141</dd>
|
|
|
|
<dd>General works WL 300</dd>
|
|
|
|
<dd>In infancy & childhood WS 340</dd>
|
|
|
|
<dd>Nursing WY 160.5</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Chief Cells, Gastric</dt>
|
|
|
|
<dd>Cytology WI 301</dd>
|
|
|
|
<dd>Physiology WI 302</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Chlorine Compounds</dt>
|
|
|
|
<dd>Inorganic chemistry QD 181.C5</dd>
|
|
|
|
<dd>Pharmacology QV 231</dd>
|
|
|
|
<dd>Water purification WA 690</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Chondrocytes WE 300
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Clavulanic Acid QV 350
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Clinical Chemistry Tests QY 90
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Cloning, Organism QH 442.2
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Cocaine-Related Disorders WM 280
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Cochlear Implantation WV 274
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Communications Media P 87-96</dt>
|
|
|
|
<dd>See also Mass Media; specific types of media, e.g., Computer</dd>
|
|
|
|
<dd> Communication Networks, Newspapers, Periodicals, Radio,</dd>
|
|
|
|
<dd> Telecommunications, Television, etc.</dd>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Conduct Disorder</dt>
|
|
|
|
<dd>General and in infancy & childhood WS 350.6</dd>
|
|
|
|
<dd>In adolescence WS 463</dd>
|
|
|
|
<dd>In adulthood WM 190</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Connective Tissue Cells QS 532.5.C7
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Contact Lens Solutions WW 355
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Corneal Topography WW 220
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Cosmetic Techniques</dt>
|
|
|
|
<dd>Surgical (General) WO 600
|
|
|
|
<dl>
|
|
|
|
<dd>Skin WR 650</dd>
|
|
|
|
<dd>Specific location, by site</dd>
|
|
|
|
</dl>
|
|
</dd>
|
|
<dd>Used for special purposes, by subject</dd>
|
|
|
|
<dd>See also Reconstructive Surgical Procedures; Surgery, Plastic;</dd>
|
|
|
|
<dd> names of specific procedures, e.g., Blepharoplasty WW 205;</dd>
|
|
|
|
<dd> Mammaplasty WP 910; Rhinoplasty WV 312</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Cruciferae</dt>
|
|
|
|
<dd>As dietary supplements in health and disease WB 430</dd>
|
|
|
|
<dd>As medicinal plants QV 766</dd>
|
|
|
|
<dd>Botany QK 495.C9</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Cytoprotection</dt>
|
|
|
|
<dd>Pharmacology (General) QV 38</dd>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Death, Sudden, Cardiac WG 205
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Decision Support Systems, Clinical</dt>
|
|
|
|
<dd>In medicine (General) W 26.55.D2</dd>
|
|
|
|
<dd>In other special fields (Form number 26.5 in any NLM schedule</dd>
|
|
|
|
<dd> where applicable)</dd>
|
|
|
|
<dd>Used for special purpose, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Delirium, Dementia, Amnestic, Cognitive Disorders</dt>
|
|
|
|
<dd>Organic mental disorders WM 140</dd>
|
|
|
|
<dd>Organic mental disorders, psychotic WM 220</dd>
|
|
|
|
<dd>See also names of specific disorders, e.g.,</dd>
|
|
|
|
<dd> Amnesia WM 173.7;</dd>
|
|
|
|
<dd> Cognition Disorders WM 204, etc.;</dd>
|
|
|
|
<dd> Delirium WL 340, etc.;</dd>
|
|
|
|
<dd> Dementia WM 220, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Dengue Hemorrhagic Fever WC 528
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Dental Physiology WU 102
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Diagnostic Equipment</dt>
|
|
|
|
<dd>(Form number 26 in any NLM schedule where applicable)</dd>
|
|
|
|
<dd>General WB 26</dd>
|
|
|
|
<dd>See also indentions under Equipment and Supplies; Equipment and</dd>
|
|
|
|
<dd> Supplies, Hospital</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Diagnostic Techniques and Procedures</dt>
|
|
|
|
<dd>General works WB 141</dd>
|
|
|
|
<dd>In infancy & childhood WS 141</dd>
|
|
|
|
<dd>In old age WT 141</dd>
|
|
|
|
<dd>See also Laboratory Techniques and Procedures QY, etc.;</dd>
|
|
|
|
<dd> names of specific diagnostic techniques; and diagnostic</dd>
|
|
|
|
<dd> techniques for specific organ systems, e.g.,</dd>
|
|
|
|
<dd> Diagnostic Techniques, Cardiovascular WG 141</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Diagnostic Techniques, Cardiovascular WG 141</dt>
|
|
|
|
<dd>See also specific diagnostic procedures, e.g.,
|
|
|
|
Angiocardiography</dd>
|
|
|
|
<dd> WG 141.5.A3; Echocardiography WG 141.5.E2</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Diagnostic Techniques, Digestive System WI 141
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Diagnostic Techniques, Endocrine WK 140
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Diagnostic Techniques, Neurological WL 141
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Diagnostic Techniques, Obstetrical and Gynecological</dt>
|
|
|
|
<dd>For gynecological conditions (General) WP 141</dd>
|
|
|
|
<dd>For obstetrical conditions (General) WQ 202</dd>
|
|
|
|
<dd> See also Pregnancy Complications WQ 240, etc.;</dd>
|
|
|
|
<dd> Pregnancy Tests QY 335;</dd>
|
|
|
|
<dd> Prenatal Diagnosis WQ 209</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Diagnostic Techniques, Ophthalmological WW 141-145
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Diagnostic Techniques, Otological WV 210
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Diagnostic Techniques, Respiratory System WF 141
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Diagnostic Techniques, Urological WJ 141
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Dietary Supplements QU 145.5</dt>
|
|
|
|
<dd>See also names of specific supplements, e.g.,</dd>
|
|
|
|
<dd> Vitamins QU 160-220, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Digestive Physiology WI 102
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Digestive System Abnormalities WI 101</dt>
|
|
|
|
<dd>In infancy & childhood WS 310</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Digestive System Fistula WI 140
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Digestive System Surgical Procedures WI 900
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Disabled Children</dt>
|
|
|
|
<dd>Education LC 4001-4806.5</dd>
|
|
|
|
<dd>Psychological problems WS 105.5.H2</dd>
|
|
|
|
<dd>Readers for disabled children PE 1126.D4</dd>
|
|
|
|
<dd>Rehabilitation
|
|
|
|
<dl>
|
|
|
|
<dd>Mentally retarded WS 107.5.R3</dd>
|
|
|
|
<dd>Physically disabled WS 368</dd>
|
|
|
|
</dl>
|
|
</dd>
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
DNA-Directed DNA Polymerase QU 141
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Dose Fractionation</dt>
|
|
|
|
<dd>Radioisotopes WN 450</dd>
|
|
|
|
<dd>Radium WN 340</dd>
|
|
|
|
<dd>X-rays WN 250.5.X7</dd>
|
|
|
|
<dd>See also Radiation Dosage WN 665</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Drug Toxicity QZ 42</dt>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Elements, Radioactive</dt>
|
|
|
|
<dd>General works WN 420</dd>
|
|
|
|
<dd>See also specific radioactive elements, e.g.,
|
|
|
|
Radium WN 300-340</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Embryonic Structures QS 604
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Emergency Treatment</dt>
|
|
|
|
<dd>Cardiac WG 205</dd>
|
|
|
|
<dd>Dental (General) WU 105</dd>
|
|
|
|
<dd>First aid WA 292</dd>
|
|
|
|
<dd>General WB 105</dd>
|
|
|
|
<dd>In infancy & childhood WS 205</dd>
|
|
|
|
<dd>Surgical WO 700-820</dd>
|
|
|
|
<dd>Veterinary (General) SF 778</dd>
|
|
|
|
<dd>Veterinary surgery SF 914.3-914.4</dd>
|
|
|
|
<dd>For specific emergencies, with the emergency, injury, disease,</dd>
|
|
|
|
<dd> or organ system involved</dd>
|
|
|
|
<dd>See also Crisis Intervention WM 401, etc.; Emergencies</dd>
|
|
|
|
<dd> WG 205, etc.; Emergency Medical Services WX 215, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Endocrine Cells of Gut WI 101</dt>
|
|
|
|
<dd>See also Gastrointestinal Hormones WK 170</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
<em>Endocrine Surgical Procedures WK 148</em>
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Endocrine System WK</dt>
|
|
|
|
<dd>General works WK 100</dd>
|
|
|
|
<dd>Of children WS 330</dd>
|
|
|
|
<dd>Physiology WK 102</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Endoscopes</dt>
|
|
|
|
<dd>(Form number 26 in any NLM schedule where applicable)</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Endospore-Forming Bacteria</dt>
|
|
|
|
<dd>General works QW 50</dd>
|
|
|
|
<dd>See also Bacteria QW, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Epidemiologic Research Design</dt>
|
|
|
|
<dd>General works WA 105</dd>
|
|
|
|
<dd>Statistics WA 900
|
|
|
|
<dl>
|
|
|
|
<dd>Theory or methods WA 950</dd>
|
|
|
|
</dl>
|
|
</dd>
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Epidemiologic Studies WA 105</dt>
|
|
|
|
<dd>Specific topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Epithelial Cells QS 532.5.E7
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Epithelium, Corneal WW 220
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Family Relations</dt>
|
|
|
|
<dd>Children WS 105.5.F2</dd>
|
|
|
|
<dd>Ethnology GN 480-480.65</dd>
|
|
|
|
<dd>Relations to health see Family Health WA 308</dd>
|
|
|
|
<dd>Relations with the mentally retarded child WS 107.5.R5</dd>
|
|
|
|
<dd>Sociology HQ 503-1064</dd>
|
|
|
|
<dd>See also specific relationship terms, e.g., Father-Child</dd>
|
|
|
|
<dd> Relations WS 105.5.F2;</dd>
|
|
|
|
<dd> Mother-Child Relations WS 105.5.F2;</dd>
|
|
|
|
<dd> Parent-Child Relations WS 105.5.F2;</dd>
|
|
|
|
<dd> Sibling Relations WS 105.5.F2</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Food Industry</dt>
|
|
|
|
<dd>Economics HD 9000-9495</dd>
|
|
|
|
<dd>Occupational medicine aspects WA 400-495</dd>
|
|
|
|
<dd>Public health aspects WA 695-722</dd>
|
|
|
|
<dd>Technology TP 368-684</dd>
|
|
|
|
<dd>See also Food Handling WA 799, etc.; Food Packaging </dd>
|
|
|
|
<dd> TP 374, etc.; Food-Processing Industry TP 368-684, etc.;</dd>
|
|
|
|
<dd> Food Technology TP 368-456, etc.; Meat-Packing</dd>
|
|
|
|
<dd> Industry TS 1970-1973, etc.; names of specific</dd>
|
|
|
|
<dd> industries and food processing activities</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Foot Bones WE 880</dt>
|
|
|
|
<dd>Deformities see Foot Deformities WE 883</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Gastric Mucosa</dt>
|
|
|
|
<dd>Cytology WI 301</dd>
|
|
|
|
<dd>Physiology WI 302</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Gonadal Disorders WK 900</dt>
|
|
|
|
<dd>See also Ovarian Diseases WP 320-322; Testicular</dd>
|
|
|
|
<dd> Diseases WJ 800-875</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Government Programs J</dt>
|
|
|
|
<dd>Programs in particular areas, by subject, e.g., National</dd>
|
|
|
|
<dd> Health Programs WA 540</dd>
|
|
|
|
<dd>Other special topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Granuloma, Respiratory Tract WF 140
|
|
|
|
<dd>See also names of specific diseases, e.g., Rhinoscleroma</dd>
|
|
|
|
<dd> WV 300; Wegener's Granulomatosis WF 600</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Gynecologic Surgical Procedures WP 660
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Health Care Evaluation Mechanisms</dt>
|
|
|
|
<dd>General works W 84</dd>
|
|
|
|
<dd>Hospitals WX 153</dd>
|
|
|
|
<dd>Private practice WB 50</dd>
|
|
|
|
<dd>Public health WA 525-546</dd>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Health Care Sector</dt>
|
|
|
|
<dd>Economics (General) W 74</dd>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Hearing Impaired Persons</dt>
|
|
|
|
<dd>Education HV 2417-2500</dd>
|
|
|
|
<dd>Rehabilitation
|
|
|
|
<dl>
|
|
|
|
<dd>Physical & medical WV 270-280</dd>
|
|
|
|
<dd>Social HV 2353-2990.5</dd>
|
|
|
|
<dd>See also Rehabilitation of Hearing Impaired</dd>
|
|
|
|
<dd> WV 270-280, etc.
|
|
|
|
</dl>
|
|
</dd>
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
<dd>See also Deafness WV 270-280; Hearing Disorders </dd>
|
|
|
|
<dd> WV 270; and terms for specific hearing disorders</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Heart Valve Prosthesis Implantation WG 169
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Hematologic Agents</dt>
|
|
|
|
<dd>General works QV 180</dd>
|
|
|
|
<dd>See also names of specific agents, e.g., Anticoagulants QV</dd>
|
|
|
|
<dd> 193; Coagulants QV 195; Hematinics QV 181</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Hemifacial Spasm WE 705
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
<em>Hepatitis, Autoimmune WI 715</em>
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Hepatitis C, Chronic WC 536
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Hot Flashes WP 580
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Immunologic Factors QW 568
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Inorganic Chemicals</dt>
|
|
|
|
<dd>Inorganic chemistry QD 146-197</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Intracranial Hypertension WL 203
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Intracranial Hypotension WL 203
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Lamiaceae QV 767
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Leg Bones WE 850
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Limb Deformities, Congenital WE 800</dt>
|
|
|
|
<dd>Of specific limb, with the limb</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Lovastatin</dt>
|
|
|
|
<dd>As an anticholesteremic agent QU 95</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Maxillofacial Abnormalities WE 705</dt>
|
|
|
|
<dd>Dental aspects WU 101.5</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Maxillofacial Prosthesis Implantation WU 600
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Mentally Disabled Persons</dt>
|
|
|
|
<dd>Education LC 4815
|
|
|
|
<dl>
|
|
|
|
<dd>See also Education of Mentally Retarded </dd>
|
|
|
|
<dd> LC 4601-4640.4, etc.</dd>
|
|
|
|
</dl>
|
|
</dd>
|
|
<dd>Medical aspects WM 300-308</dd>
|
|
|
|
<dd>Social aspects HV 3004-3009
|
|
|
|
<dl>
|
|
|
|
<dd>Transportation HV 3005.5</dd>
|
|
|
|
<dd>Vocational guidance HV 3005</dd>
|
|
|
|
</dl>
|
|
</dd>
|
|
<dd>See also Disabled Children LC 4001-4806.5, etc.;</dd>
|
|
|
|
<dd> Mental Retardation WM 300-308, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Motor Skills Disorders</dt>
|
|
|
|
<dd>Developmental WS 340</dd>
|
|
|
|
<dd>Neurologic WL 390</dd>
|
|
|
|
<dd>Psychogenic WM 197</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Musculoskeletal Abnormalities WE 101
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Musculoskeletal Physiology WE 102
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Neck Injuries WE 708
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Neoplasms, Adipose Tissue QZ 340</dt>
|
|
|
|
<dd>Localized, by site</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Neoplastic Processes QZ 202
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Nervous System Physiology WL 102</dt>
|
|
|
|
<dd>See also Neurophysiology WL 102</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Neurodegenerative Diseases WL 359
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Neurosurgical Procedures WL 368
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Obstetric Surgical Procedures WQ 400-450
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Ocular Physiology WW 103
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Oligopeptides QU 68
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Ophthalmologic Surgical Procedures WW 168</dt>
|
|
|
|
<dd>See also Surgery WW 168 under Eye Diseases</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Ophthalmoscopes WW 26
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Optic Nerve Neoplasms WW 280
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Oral Fistula</dt>
|
|
|
|
<dd>General works for the dentist WU 140</dd>
|
|
|
|
<dd>General works for the gastroenterologist WI 200</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Oral Surgical Procedures WU 600-640</dt>
|
|
<dd>Atlases WU 600.7</dd>
|
|
|
|
<dd>In infancy & childhood WU 480</dd>
|
|
|
|
<dd>See also Surgery, Oral WU 600-640, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Organic Chemicals</dt>
|
|
|
|
<dd>Organic chemistry QD 241-441</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Orthopedic Procedures WE 168-190</dt>
|
|
|
|
<dd>General works WE 168</dd>
|
|
|
|
<dd>In infancy & childhood WS 270</dd>
|
|
|
|
<dd>Nursing WY 157.6</dd>
|
|
|
|
<dd>Reconstructive orthopedic procedures WE 190</dd>
|
|
|
|
<dd>Veterinary SF 910.5</dd>
|
|
|
|
<dd>See also names of particular bones, joints, or procedures;</dd>
|
|
|
|
<dd> Orthopedics WE 168-190, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Ossicular Prosthesis WV 230
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Ossicular Replacement WV 230
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Osteogenesis, Distraction WE 168</dt>
|
|
|
|
<dd>In oral surgery WU 600</dd>
|
|
|
|
<dd>Localized, by site</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Otologic Surgical Procedures WV 200</dt>
|
|
|
|
<dd>See also Surgery WV 200 under Ear</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Otorhinolaryngologic Surgical Procedures WV 168</dt>
|
|
|
|
<dd>See also Surgery WV 168 under Otorhinolaryngologic Diseases</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Otoscopes WV 26
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Oxygen Compounds QV 312
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Pan paniscus QL 737.P96</dt>
|
|
|
|
<dd>As laboratory animals QY 60.P7</dd>
|
|
|
|
<dd>Diseases SF 997.5.P7</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Paneth Cells WI 500
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Parasitic Diseases, Animal SF 810.A3
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Patient Care W 84-84.8</dt>
|
|
|
|
<dd>Of hospital patients WX 162-162.5</dd>
|
|
|
|
<dd>See also names of specific types of care, e.g., Nursing Care</dd>
|
|
|
|
<dd> WY 100, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Patient Care Management W 84.7</dt>
|
|
|
|
<dd>In nursing WY 100</dd>
|
|
|
|
<dd>Of hospital patients WX 162-162.5</dd>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Penile Implantation WJ 790</dt>
|
|
|
|
<dd>For the treatment of impotence WJ 709</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Perioperative Care WO 178</dt>
|
|
|
|
<dd>See also Perioperative Nursing WY 161, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Peripheral Nervous System Agents QV 76.5
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Pharmaceutical Solutions QV 786</dt>
|
|
|
|
<dd>Used for specific purposes, by subject</dd>
|
|
|
|
<dd>See also specific solution terms, e.g., Contact Lense Solutions</dd>
|
|
|
|
<dd> WW 355; Hypertonic Solutions QV 786; Isotonic</dd>
|
|
|
|
<dd> Solutions QV 786; Ophthalmic Solutions WW 166</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Pharmacoepidemiology QZ 42</dt>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Physiological Processes</dt>
|
|
|
|
<dd>Domestic animals SF 768-768.2</dd>
|
|
|
|
<dd>General QT 4</dd>
|
|
|
|
<dd>Human (General) QT 104</dd>
|
|
|
|
<dd>Plants see Plant Physiology QK 710-899</dd>
|
|
|
|
<dd>Wild animals QP, etc.</dd>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
<dd>See also Adaptation, Physiological QT 140, etc.;</dd>
|
|
|
|
<dd> Physiology QT, etc.; specific physiology terms, and</dd>
|
|
|
|
<dd> indentions for physiology under various topics</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Plant Physiology QK 710-899
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Population Characteristics HB 848-3697</dt>
|
|
|
|
<dd>Health problems of special population groups WA 300-395</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Progeria WS 104</dt>
|
|
|
|
<dd>In adults see Werner Syndrome QZ 45</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Prosthesis Implantation WE 172</dt>
|
|
|
|
<dd>Of specific prosthesis, with the prosthesis</dd>
|
|
|
|
<dd>See also Prosthesis WE 172; names of specific implants,</dd>
|
|
|
|
<dd> prostheses, or prosthesis implantation</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Protozoan Infections, Animal SF 780.6
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Psychotherapeutic Processes WM 420</dt>
|
|
|
|
<dd>In adolescence WS 463</dd>
|
|
|
|
<dd>In infancy & childhood WS 350.2</dd>
|
|
|
|
<dd>In old age WT 150</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Pulmonary Surgical Procedures WF 668
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Quality Indicators, Health Care</dt>
|
|
|
|
<dd>General W 84</dd>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Radiography, Abdominal WI 900
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Radiologic Health WN 600
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Reconstructive Surgical Procedures WO 600-640</dt>
|
|
|
|
<dd>Specific locations, by site</dd>
|
|
|
|
<dd>See also Cosmetic Techniques; Surgery, Plastic; specific</dd>
|
|
|
|
<dd> reconstructive surgical procedures, e.g., Blepharoplasty </dd>
|
|
|
|
<dd> WW 205; Mammaplasty WP 910;</dd>
|
|
|
|
<dd> Rhinoplasty WV 312</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Rehabilitation of Hearing Impaired</dt>
|
|
|
|
<dd>Physical & medical WV 270-280</dd>
|
|
|
|
<dd>Social HV 2353-2990.5</dd>
|
|
|
|
<dd>See also specific rehabilitation devices and procedures, e.g.,</dd>
|
|
|
|
<dd> Hearing Aids WV 274; Sign Language HV 2474-2476</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Reproductive Control Agents QV 170
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Resource Guides</dt>
|
|
|
|
<dd>(Form number 39 in any NLM schedule where applicable)</dd>
|
|
|
|
<dd>Anesthesiology WO 231</dd>
|
|
|
|
<dd>Animal poisoning WD 401</dd>
|
|
|
|
<dd>Aviation and space medicine WD 701</dd>
|
|
|
|
<dd>Dentistry WU 49</dd>
|
|
|
|
<dd>Diseases and injuries caused by physical agents WD 601</dd>
|
|
|
|
<dd>Embryology QS 629</dd>
|
|
|
|
<dd>Forensic medicine and dentistry W 639</dd>
|
|
|
|
<dd>Histology QS 529</dd>
|
|
|
|
<dd>Immunologic diseases. Hypersensitivity. Collagen diseases</dd>
|
|
|
|
<dd> WD 301</dd>
|
|
|
|
<dd>Immunology QW 539</dd>
|
|
|
|
<dd>Medicine W 49</dd>
|
|
|
|
<dd>Metabolic diseases WD 200.1</dd>
|
|
|
|
<dd>Nursing WY 49</dd>
|
|
|
|
<dd>Nutrition disorders WD 101</dd>
|
|
|
|
<dd>Pharmacy QV 735</dd>
|
|
|
|
<dd>Physiology QT 29</dd>
|
|
|
|
<dd>Plant poisoning WD 501</dd>
|
|
|
|
<dd>Psychiatry WM 34</dd>
|
|
|
|
<dd>Toxicology QV 607</dd>
|
|
|
|
<dd>See also Abstracts; Bibliography; Directories; Handbooks;</dd>
|
|
|
|
<dd> Indexes</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Respiratory Physiology WF 102
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Respiratory System Abnormalities WF 101</dt>
|
|
|
|
<dd>In infancy & childhood WS 280</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Respiratory Tract Fistula WF 140
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Retinal Neoplasms WW 270
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Retrocochlear Diseases WL 330</dt>
|
|
|
|
<dd>See also Hearing Loss, Sensorineural WV 270-276</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Rhytidoplasty WE 705
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
RNA Virus Infections WC 501
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Rosales</dt>
|
|
|
|
<dd>As a dietary supplement in health or disease WB 430</dd>
|
|
|
|
<dd>As a medicinal plant QV 766</dd>
|
|
|
|
<dd>See also names of specific plants and processed foods, e.g.,</dd>
|
|
|
|
<dd> Wine WB 444, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Sebaceous Gland Diseases WR 410
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Sensory System Agents QV 76.5</dt>
|
|
|
|
<dd>See also specific kinds of agents, e.g., Analgesics QV 95; Anesthetics, Local QV 110-115</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Sex Determination (Genetics) QS 638</dt>
|
|
|
|
<dd>See also Sex Determination (Analysis) WQ 206;</dd>
|
|
|
|
<dd> Sex Differentiation QS 640</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Sexual and Gender Disorders WM 611
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Signs and Symptoms</dt>
|
|
|
|
<dd>Digestive system diseases see Signs and Symptoms,</dd>
|
|
|
|
<dd> Digestive WI 143</dd>
|
|
|
|
<dd>General WB 143</dd>
|
|
|
|
<dd>Intestinal diseases WI 405</dd>
|
|
|
|
<dd>Otorhinolaryngologic diseases WV 150</dd>
|
|
|
|
<dd>Pain WB 176</dd>
|
|
|
|
<dd>Respiratory tract diseases see Signs and Symptoms,</dd>
|
|
|
|
<dd> Respiratory WF 143</dd>
|
|
|
|
<dd>Specific diseases with disease, in diagnosis number if</dd>
|
|
|
|
<dd> available</dd>
|
|
|
|
<dd>Thinness WB 146</dd>
|
|
|
|
<dd>See also Eye Manifestations WW 475, etc.; Neurologic</dd>
|
|
|
|
<dd> Manifestations WL 340, etc.; Oral Manifestations</dd>
|
|
|
|
<dd> WU 290; Skin Manifestations WR 143</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Signs and Symptoms, Digestive WI 143
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Signs and Symptoms, Respiratory WF 143
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Simvastatin</dt>
|
|
|
|
<dd>As an anticholesteremic agent QU 95</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Skeletal Muscle Ventricle</dt>
|
|
|
|
<dd>Used in cardiomyoplasty WG 169</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Skin Abnormalities</dt>
|
|
|
|
<dd>General WR 218</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Skin Diseases, Genetic WR 218
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Skin Diseases, Metabolic</dt>
|
|
|
|
<dd>General WR 140</dd>
|
|
|
|
<dd>See also names of specific disorders, e.g., Adiposis</dd>
|
|
|
|
<dd> Dolorosa WD 214</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Skin Physiology WR 102
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Sodium Azide QU 54
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Sphygmomanometers WG 26
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Spinal Curvatures WE 735</dt>
|
|
|
|
<dd>See also names of specific disorders, e.g., Kyphosis,</dd>
|
|
|
|
<dd> Lordosis, Scoliosis</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Sports Equipment</dt>
|
|
|
|
<dd>General QT 26</dd>
|
|
|
|
<dd>For a specific sport, with the sport</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Stereotypic Movement Disorder WM 197
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Stomas</dt>
|
|
|
|
<dd>General WI 900</dd>
|
|
|
|
<dd>Nursing WY 161</dd>
|
|
|
|
<dd>Created for a specific organ, with the organ, e.g.,</dd>
|
|
|
|
<dd> Colon WI 520</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Stomatognathic System Abnormalities WU 101.5
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Sulfur Compounds QV 265
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Thoracic Surgical Procedures WF 980
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Thrombophilia QZ 170
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Thrombospondins QU 55
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Tissue Expansion</dt>
|
|
|
|
<dd>General WO 600</dd>
|
|
|
|
<dd>Localized, by site</dd>
|
|
|
|
<dd>For specific conditions, with the condition</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Tooth Components WU 220-230</dt>
|
|
|
|
<dd>See also names of specific components, e.g., Dental</dd>
|
|
|
|
<dd> Enamel WU 220; Dental Pulp WU 230</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Transplants WO 660-690</dt>
|
|
|
|
<dd>Specific organs, tissues, or cells; with the organ,</dd>
|
|
|
|
<dd> tissue or cell</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Urinary Tract Physiology WJ 102
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Urogenital Abnormalities WJ 101
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Urogenital Surgical Procedures WJ 168
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Urologic Surgical Procedures WJ 168
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Urologic Surgical Procedures, Male</dt>
|
|
|
|
<dd>General works WJ 700</dd>
|
|
|
|
<dd>See also Urogenital Surgical Procedures WJ 168</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Vascular Fistula
|
|
|
|
<dd>General WG 500</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Viral Physiology QW 160
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Visually Impaired Persons</dt>
|
|
|
|
<dd>Rehabilitation
|
|
|
|
<dl>
|
|
|
|
<dd>Physical & medical
|
|
|
|
<dl>
|
|
|
|
<dd>Blind WW 276</dd>
|
|
|
|
<dd>Vision disorders (General) WW 140</dd>
|
|
|
|
</dl>
|
|
</dd>
|
|
|
|
<dd>Social HV 1573-2349</dd>
|
|
|
|
</dl>
|
|
|
|
</dd>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
<dd>See also Blindness WW 276, etc.; Vision Disorders</dd>
|
|
|
|
<dd> WW 140, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Werner Syndrome QZ 45
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Wolves QL 737.C22
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Zingiberales</dt>
|
|
|
|
<dd>As dietary supplements in health and disease WB 430</dd>
|
|
|
|
<dd>As medicinal plants QV 766</dd>
|
|
|
|
<dd>Botany QK 495.A14
|
|
|
|
<dl>
|
|
|
|
<dd>Zingiberaceae (Ginger) QK 495.Z65</dd>
|
|
|
|
</dl>
|
|
</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>2-Propanol</dt>
|
|
|
|
<dd>Pharmacology QV 82</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<br /><br />
|
|
|
|
|
|
|
|
|
|
|
|
<center><strong><a name="index" id="index">Notable Changes in the Index</a></strong></center>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Note: Minor changes such as adding subindexes under specific
|
|
|
|
existing Index terms are not listed in this chart.
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<table width=440>
|
|
|
|
|
|
|
|
<tr valign=top><td width=220></td><td width=220></td></tr>
|
|
|
|
|
|
|
|
<tr valign=top><td width=220><strong>Page Reference</strong></td><td width=220><strong>Change</strong></td></tr>
|
|
|
|
|
|
|
|
<tr valign=top><td width=220>p. I-112 at Hepatitis</td><td width=220>change classification no.
|
|
|
|
from: WI 700 to WI 715</td></tr>
|
|
|
|
|
|
|
|
<tr valign=top><td width=220>p. I-112 at Hepatitis, Alcoholic</td><td width=220>change classification no.
|
|
|
|
from: WI 700 to WI 715</td></tr>
|
|
|
|
|
|
|
|
<tr valign=top><td width=220>p. I-113 at Hepatitis, Chronic
|
|
|
|
Active WC 536</td><td width=220>change to:<br />
|
|
|
|
Hepatitis, Chronic<br />
|
|
|
|
General or unspecified WI<br />
|
|
|
|
715<br />
|
|
|
|
See also specific names of<br />
|
|
|
|
Hepatitis, e.g., Hepatitis
|
|
|
|
C,<br /> Chronic WC 536</td></tr>
|
|
|
|
<tr valign=top><td width=220>p. I-113 at Hepatitis, Toxic</td><td width=220>change classification no.
|
|
|
|
from: WI 700 to WI 715</td></tr>
|
|
|
|
</table>
|
|
|
|
|
|
|
|
<br /><br />
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dd><em>--prepared by Wen-Min Kao</em></dd>
|
|
|
|
<dd>Technical Services Division</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
</td>
|
|
|
|
</tr>
|
|
|
|
<tr><td valign=top bgcolor="#CB9966" width=140>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
<a href="/pubs/techbull/nd98/nd98_class.html">Table of contents</a>
|
|
|
|
</p>
|
|
|
|
<p>
|
|
<a href="/pubs/techbull/tb.html">Home</a>
|
|
</p>
|
|
|
|
<p>
|
|
<a href="/pubs/techbull/new_index.html">Index</a>
|
|
</p>
|
|
</td>
|
|
</tr>
|
|
</table>
|
|
|
|
<br />
|
|
<hr />
|
|
<!-- BEGIN NLM FOOTER -->
|
|
<center>
|
|
<font size="2" face="helvetica, arial"><a href="/nlmhome.html">U.S. National Library of Medicine</a>, 8600 Rockville Pike, Bethesda, MD 20894<br /><a href="http://www.nih.gov/">National Institutes of Health</a>, <a href="//www.hhs.gov/">Department of Health & Human Services</a><br /><a href="/copyright.html">Copyright</a>, <a href="/privacy.html">Privacy</a>, <a href="/accessibility.html">Accessibility</a>, <a href="http://www.nih.gov/icd/od/foia/index.htm">Freedom of Information Act (FOIA)</a><br/><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html">HHS Vulnerability Disclosure</a>
|
|
<br />
|
|
<!-- ******************MODIFY "LAST UPDATED" ******************* -->
|
|
Last updated: 18 April 2012
|
|
</font>
|
|
</center>
|
|
|
|
<!-- END NLM FOOTER -->
|
|
<!-- ******************MODIFY EXPDATE AND EMAIL BELOW****************** -->
|
|
<!-- EXPDATE="2015-03-20" -->
|
|
<!-- EMAIL="nlmtechbull@mail.nlm.nih.gov" -->
|
|
<script src="//assets.nlm.nih.gov/jquery/jquery-latest.min.js"></script><script src="/core/nlm-notifyExternal/1.0/nlm-notifyExternal.min.js"></script></body>
|
|
</html>
|
|
|